Cervical Cancer Management Guidelines

Diagnosis and Staging

The National Comprehensive Cancer Network recommends a complete history and physical examination, with special attention to symptoms such as abnormal bleeding, for patients with suspected cervical cancer 3, 4
Cervical biopsy with pathologic review is essential for diagnosis, and cone biopsy may be necessary to define invasiveness or assess microinvasive disease 1, 5
Imaging studies, including MRI, CT, and PET/CT, are used to determine tumor size, stromal penetration, and lymph node involvement, with MRI recommended for patients with visible cervical carcinoma (except FIGO stage IV) 3, 7, 8, 9

For stage IA1 cervical cancer without lymphovascular space invasion, the National Comprehensive Cancer Network recommends fertility-sparing options, such as cone biopsy with negative margins, or non-fertility-sparing options, such as extrafascial hysterectomy 2, 5
For stage IA2 cervical cancer, radical trachelectomy and pelvic lymph node dissection are recommended for fertility-sparing, while radical hysterectomy and bilateral pelvic lymph node dissection are recommended for non-fertility-sparing 2, 5, 7
For stages IB1 and IIA1 cervical cancer, radical hysterectomy with pelvic lymphadenectomy or radiotherapy are recommended, with similar efficacy but different morbidity profiles 2, 7
For locally advanced cervical cancer (stages IB2-IVA/IB3-IVA), concurrent chemoradiation is the standard treatment, with definitive radiation therapy including pelvic external beam radiation, intracavitary brachytherapy, and high doses (>80-90 Gy) administered in a short time (<55 days) 7, 9, 10

The National Comprehensive Cancer Network recommends that sexual function be assessed before treatment, and women be offered information, training, and support for sexual concerns before and after treatment 3, 8
Young women (<45 years) with early-stage squamous cell carcinoma who opt for hysterectomy may consider ovarian preservation, as the rate of ovarian metastases is low 2
Smoking cessation should be advised for all patients, as it can improve treatment outcomes 6, 5

Cervical cytologic screening methods are less useful for diagnosing adenocarcinoma compared to squamous cell carcinoma, and treatment must be completed within the recommended timeframe (<55 days) for optimal outcomes 1, 5, 7, 9
Small cell neuroendocrine histology and adenoma malignum are not suitable for fertility-sparing procedures, and unscheduled cervical smears are not recommended outside the screening program 2, 3, 4, 5